Taisei J. Kobayashi, MD

faculty photo
Assistant Professor of Clinical Medicine (Cardiovascular Medicine)
Co-Director of the Coronary Chronic Total Occlusion Team, Hospital of the University of Pennsylvania
Leadership committee of the Pulmonary Embolism Response Team, Hospital of the University of Pennsylvania
Co-Director of the Penn Denervation Center, Hospital of the University of Pennsylvania
Director of Interventional Cardiovascular Services, Michael J Crescenz Veterans Affairs Hospital
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
11th Floor South Pavilion
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-614-6093
Fax: 215-349-5894
Johns Hopkins University, 2006.
MD (Medicine)
Case Western Reserve University, 2010.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Renal Denervation
Complex Coronary Interventions
Chronic Total Occlusions
Endovascular Arterial and Venous interventions
Pulmonary Arterial Sensor implantation
Advanced management and escalation of interventional therapies for Deep Venous thrombosis and pulmonary embolism
Structural heart disease including TAVR
Cardiogenic shock interventions including percutaneous mechanical support

Description of Research Expertise

Radiofrequency Renal Denervation
Ultrasound Renal Denervation
COVID - 19 related cardiovascular disease
Cardiovascular Outcomes research
Pulmonary Embolism
TAVR outcomes research

Selected Publications

Kobayashi T, Pugliese S, Sethi S, Parikh S, Goldberg J, Aljhafan F, Vitarello C, Rosenfield K, Lookstein R, Keeling B, Klein A, Gibson M, Glassmoyer L, Khandhar S, Secemsky E, Giri J.: Contemporary Management and Outcomes of Patients With High-Risk Pulmonary Embolism. Journal of the American College of Cardiology. Journal of the American College of Cardiology, 83(1): 35-43, January 2024.

Fulton B, Bashir R, Weinberg M, Lakhter V, Rali P, Pugliese S, Giri J, Kobayashi T.: Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up. Thieme Medical. Thieme Medical Publishers, Inc, 49(8), November 2023.

Julien H, Wang Y, Curtis J, Johnston-Cox H, Eberly L, Wang G, Nathan A, Fanaroff A, Khatana S, Groeneveld P, Secemsky E, Eneanya N, Vora A, Kobayashi T, Barbery C, Chery Godery, Kohi M, Kirksey L, Armstrong E, Jaff M, Giri J.: Racial Differences in Presentation and Outcomes After Peripheral Arterial Interventions: Insights From the NCDR-PVI Registry. Circulation: Cardiovascular Interventions. AHA Journal, 16(6): Epub, June 2023.

Reddy KP, Eberly LA, Halaby R, Julien H, Khatana SAM, Dayoub EJ, Coylewright M, Alkhouli M, Fiorilli PN, Kobayashi TJ, Goldberg DM, Herrmann HC, Giri J, Groeneveld PW, Fanaroff AC, Nathan AS.: Racial, Ethnic and Socioeconomic Inequities in Access to Left Atrial Appendage Occlusion. J Am Heart Association 12(5), Feb 2023.

Nathan AS, Reddy KP, Yang L, Eberly LA, Dayoub EJ, Khatana SAM, Julien HM, Desai ND, Szeto WY, Herrmann HC, Kobayashi TJ, Fiorilli P, Batchelor WB, Mehran R, Alkhouli MA, Giri J, Groeneveld PW, Fanaroff AC.: Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies. JAMA Cardiology 1(8): 120-128, Feb 2023.

Goldberg JB, Giri J, Kobayashi T, Ruel M, Mittnacht AJC, Rivera-Lebron B, DeAnda A Jr, Moriarty JM, MacGillivray TE. : Surgical Management and Mechanical Circulatory Support in High-Risk Pulmonary Embolisms: Historical Context, Current Status, and Future Directions: A Scientific Statement from the American Heart Association. Circulation 147(9): 628-647, Jan 2023.

Fulton B, Giri JS, Cohen DL, Secemsky EA, Aronow HD, Kobayashi T.: Renal Denervation in the Treatment of Resistant Hypertension. http://www.acc.org. Nov 2022 Notes: https://www.acc.org/Latest-in-Cardiology/Articles/2022/11/28/12/46/Renal-Denervation-in-the-Treatment-of-Resistant-Hypertension.

Fulton B, Giri J, Cohen DL, Aronow HD, Kobayashi T.: How to Denervate with Current Renal Denervation Device Iterations: A step-by-step to renal denervation for the treatment of hypertension. Cardiac Interventions Today 16(5): 32-35, Oct 2022.

Nathan AS, Geng Z, Eberly LA, Eneanya ND, Dayoub EJ, Khatana SAM, Kolansky DM, Kobayashi TJ, Tuteja S, Fanaroff AC, Giri J, Groeneveld PW: Identifying Racial, Ethnic, and Socioeconomic Inequities in the Use of Novel P2Y12 inhibitors after percutaneous coronary intervention. J Invasive Cardiol 34(3): E171-E178, March 2022.

Vidula MK, Orlenko A, Zhao L, Salvador L, Small AM, Horton E, Cohen JB, Adusumalli S, Denduluri S, Kobayashi T, Hyman M, Fiorilli P, Magro C, Singh B, Pourmussa B, Greczylo C, Basso M, Ebert C, Yarde M, Li Z, Cvijic ME, Wang Z, Walsh A, Maranville J, Kick E, Luettgen J, Adam L, Schafer P, Ramirez-Valle F, Seiffert D, Moore JH, Gordon D, Chirinos JA: Plasma Biomarkers Associated with Adverse outcomes in patients with Calcific Aortic stenosis. Eur J Heart Fail 23(12): 2021-2032, Dec 2021.

back to top
Last updated: 05/09/2024
The Trustees of the University of Pennsylvania